References
- Green DM, Liu W, Kutteh WH, et al. Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude lifetime cohort study. Lancet Oncol. 2014;15(11):215–1223.
- Delessard M, Saulnier J, Rives A, et al. Exposure to chemotherapy during childhood or adulthood and consequences on spermatogenesis and male fertility. IJMS. 2020;21(4):1454.
- Meissner J, Tichy D, Dietrich S, et al. Parenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma. Br J Haematol. 2014;166(4):612–615.
- Lasica M, Taylor E, Bhattacharyya P, et al. Fertility in premenopausal women post autologous stem cell transplant with BEAM conditioning. Eur J Haematol. 2016;97(4):348–352.
- Jacob A, Barker H, Goodman A, et al. Recovery of spermatogenesis following bone marrow transplantation. Bone Marrow Transplant. 1998;22(3):277–279.
- Kiserud C, A Fossa A, Holte H, et al. Post-treatment parenthood in hodgkin’s lymphoma survivors. Br J Cancer. 2007;96(9):1442–1449.
- Chatterjee R, Haines G, Perera D, et al. Testicular and sperm DNA damage after treatment with fludarabine for chronic lymphocytic leukaemia. Hum Reprod. 2000;15(4):762–766.
- Almagor M, Dan-Goor M, Hovav Y, et al. Spontaneous pregnancies in severe oligoasthenozoospermia. Hum Reprod. 2001;16(8):1780–1781.
- Grigg A, McLachlan R, J Zajac J, et al. Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg). Bone Marrow Transplant. 2000;26(10):1089–1095.
- Wang Y, Liu M, Johnson S, et al. Doxorubicin obliterates mouse ovarian reserve through both primordial follicle atresia and overactivation. Toxicol Appl Pharmacol. 2019;381:114714.
- Feijen EAM, Leisenring WM, Stratton KL, et al. Equivalence ratio for daunorubicin to doxorubicin in relation to late heart failure in survivors of childhood cancer. J Clin Oncol. 2015;33(32):3774–3780.
- Harel S, Ferme C, Poirot C. Management of fertility in patients treated for hodgkin’s lymphoma. Haematologica. 2011;96(11):1692–1699.
- Valsamakis G, Valtetsiotis K, Charmandari E, et al. GnRH analogues as a co-treatment to therapy in women of reproductive age with cancer and fertility preservation. IJMS. 2022;23(4):2287.
- Behringer K, Mueller H, Goergen H, et al. Fertility and gonadal function in female survivors after treatment of early unfavorable hodgkin lymphoma (HL) within the german hodgkin study group HD14 trial. Ann Oncol. 2012;23(7):1818–1825.
- Faraci M, Matthes-Martin S, Lanino E, et al. Two pregnancies shortly after transplantation with reduced intensity conditioning in chronic myeloid leukemia. Pediatr Transplant. 2016;20(1):158–161.
- Singhal S, Powles R, Treleaven J, et al. Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women. Bone Marrow Transplant. 1996;18(6):1049–1055.
- Even-Or E, Ben-Haroush A, Yahel A, et al. Fertility after treatment with high-dose melphalan in women with acute myelogenous leukemia. Pediatr Blood Cancer. 2016;63(2):334–336.
- Chabut M, Schneider P, Courbiere B, et al. Ovarian function and spontaneous pregnancy after hematopoietic stem cell transplantation for leukemia before puberty an L.E.A. cohort study. Transplant Cell Ther. 2023 Feb 26;S2666-6367(23)01130-2.